NDC 69238-2860 – Mirabegron
Mirabegron 25 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC69238-2860
Product details
- Brand name
- Mirabegron
- Generic name
- Mirabegron
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA218543
- Marketed since
- April 19, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- beta3-Adrenergic Agonist
Active ingredients
- Mirabegron 25 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 69238-2860-1 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2860-1) | Apr 19, 2026 |
| 69238-2860-2 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69238-2860-2) | Apr 19, 2026 |
Other Mirabegron products
- 69238-2861 Mirabegron 50 mg/1 · Tablet, Film Coated, Extended Release · Amneal Pharmaceuticals NY LLC
- 71335-2807 Mirabegron 25 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 71335-2808 Mirabegron 50 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 71335-2809 Mirabegron 25 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 71335-2810 Mirabegron 50 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 68180-151 Mirabegron 25 mg/1 · Tablet, Film Coated, Extended Release · Lupin Pharmaceuticals, Inc.
- 68180-152 Mirabegron 50 mg/1 · Tablet, Film Coated, Extended Release · Lupin Pharmaceuticals, Inc.
- 67184-0571 Mirabegron 25 mg/1 · Tablet, Film Coated, Extended Release · Qilu Pharmaceutical Co., Ltd.
- 70518-4665 Mirabegron 50 mg/1 · Tablet, Film Coated, Extended Release · REMEDYREPACK INC.
- 67877-890 Mirabegron 8 mg/mL · For Suspension, Extended Release · Ascend Laboratories, LLC
- 70518-4304 Mirabegron 50 mg/1 · Tablet, Extended Release · REMEDYREPACK INC.
- 70518-4631 Mirabegron 25 mg/1 · Tablet, Extended Release · REMEDYREPACK INC.